Phase II Randomized Study of Trastuzumab Emtansine Versus Trastuzumab Plus Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer
HURVITZ, Sara A, DIRIX, Luc, CHU, Yu-Waye, PEREZ, Edith A, KOCSIS, Judit, BIANCHI, Giulia V, LU, Janice, VINHOLES, Jeferson, GUARDINO, Ellie, CHUNYAN SONG, TONG, Barbara, NG, Vivian
Published in Journal of clinical oncology (20.03.2013)
Published in Journal of clinical oncology (20.03.2013)
Get full text
Journal Article
Safety and activity of the anti-CD79B antibody–drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study
Palanca-Wessels, Maria Corinna A, Dr, Czuczman, Myron, Prof, Salles, Gilles, Prof, Assouline, Sarit, MD, Sehn, Laurie H, MD, Flinn, Ian, MD, Patel, Manish R, MD, Sangha, Randeep, MD, Hagenbeek, Anton, MD, Advani, Ranjana, MD, Tilly, Herve, Prof, Casasnovas, Olivier, MD, Press, Oliver W, Prof, Yalamanchili, Sreeni, PharmD, Kahn, Robert, MD, Dere, Randall C, BSc, Lu, Dan, PhD, Jones, Surai, MS, Jones, Cheryl, ScD, Chu, Yu-Waye, MD, Morschhauser, Franck, Prof
Published in The lancet oncology (01.06.2015)
Published in The lancet oncology (01.06.2015)
Get full text
Journal Article
Phase II Study of the Antibody Drug Conjugate Trastuzumab-DM1 for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2) –Positive Breast Cancer After Prior HER2-Directed Therapy
BURRIS, Howard A, RUGO, Hope S, AMLER, Lukas, MAOXIA ZHENG, CHU, Yu-Waye, KLENCKE, Barbara, O'SHAUGHNESSY, Joyce A, VUKELJA, Svetislava J, VOGEL, Charles L, BORSON, Rachel A, LIMENTANI, Steven, TAN-CHIU, Elizabeth, KROP, Ian E, MICHAELSON, Richard A, GIRISH, Sandhya
Published in Journal of clinical oncology (01.02.2011)
Published in Journal of clinical oncology (01.02.2011)
Get full text
Journal Article
An anti-CD3/anti–CLL-1 bispecific antibody for the treatment of acute myeloid leukemia
Leong, Steven R., Sukumaran, Siddharth, Hristopoulos, Maria, Totpal, Klara, Stainton, Shannon, Lu, Elizabeth, Wong, Alfred, Tam, Lucinda, Newman, Robert, Vuillemenot, Brian R., Ellerman, Diego, Gu, Chen, Mathieu, Mary, Dennis, Mark S., Nguyen, Allen, Zheng, Bing, Zhang, Crystal, Lee, Genee, Chu, Yu-Waye, Prell, Rodney A., Lin, Kedan, Laing, Steven T., Polson, Andrew G.
Published in Blood (02.02.2017)
Published in Blood (02.02.2017)
Get full text
Journal Article
Mitigating the risk of cytokine release syndrome in a Phase I trial of CD20/CD3 bispecific antibody mosunetuzumab in NHL: impact of translational system modeling
Hosseini, Iraj, Gadkar, Kapil, Stefanich, Eric, Li, Chi-Chung, Sun, Liping L., Chu, Yu-Waye, Ramanujan, Saroja
Published in NPJ systems biology and applications (28.08.2020)
Published in NPJ systems biology and applications (28.08.2020)
Get full text
Journal Article
Phase I Study of the Anti-CD22 Antibody-Drug Conjugate Pinatuzumab Vedotin with/without Rituximab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Advani, Ranjana H, Lebovic, Daniel, Chen, Andy, Brunvand, Mark, Goy, Andre, Chang, Julie E, Hochberg, Ephraim, Yalamanchili, Sreeni, Kahn, Robert, Lu, Dan, Agarwal, Priya, Dere, Randall C, Hsieh, Hsin-Ju, Jones, Surai, Chu, Yu-Waye, Cheson, Bruce D
Published in Clinical cancer research (01.03.2017)
Published in Clinical cancer research (01.03.2017)
Get full text
Journal Article
Clinical pharmacology of trastuzumab emtansine (T-DM1): an antibody–drug conjugate in development for the treatment of HER2-positive cancer
Girish, Sandhya, Gupta, Manish, Wang, Bei, Lu, Dan, Krop, Ian E., Vogel, Charles L., Burris III, Howard A., LoRusso, Patricia M., Yi, Joo-Hee, Saad, Ola, Tong, Barbara, Chu, Yu-Waye, Holden, Scott, Joshi, Amita
Published in Cancer chemotherapy and pharmacology (01.05.2012)
Published in Cancer chemotherapy and pharmacology (01.05.2012)
Get full text
Journal Article
Catabolic fate and pharmacokinetic characterization of trastuzumab emtansine (T-DM1): an emphasis on preclinical and clinical catabolism
Shen, Ben-Quan, Bumbaca, Daniela, Saad, Ola, Yue, Qin, Pastuskovas, Cinthia V, Khojasteh, S Cyrus, Tibbitts, Jay, Kaur, Surinder, Wang, Bei, Chu, Yu-Waye, LoRusso, Patricia M, Girish, Sandhya
Published in Current drug metabolism (01.09.2012)
Published in Current drug metabolism (01.09.2012)
Get more information
Journal Article
Clinical implications of pathophysiological and demographic covariates on the population pharmacokinetics of trastuzumab emtansine, a HER2-targeted antibody-drug conjugate, in patients with HER2-positive metastatic breast cancer
Gupta, Manish, Lorusso, Patricia M, Wang, Bei, Yi, Joo-Hee, Burris, 3rd, Howard A, Beeram, Muralidhar, Modi, Shanu, Chu, Yu-Waye, Agresta, Samuel, Klencke, Barbara, Joshi, Amita, Girish, Sandhya
Published in Journal of clinical pharmacology (01.05.2012)
Published in Journal of clinical pharmacology (01.05.2012)
Get more information
Journal Article
Exogenous insulin-like growth factor 1 enhances thymopoiesis predominantly through thymic epithelial cell expansion
Chu, Yu-Waye, Schmitz, Sabrina, Choudhury, Baishakhi, Telford, William, Kapoor, Veena, Garfield, Susan, Howe, David, Gress, Ronald E.
Published in Blood (01.10.2008)
Published in Blood (01.10.2008)
Get full text
Journal Article
CCL25 increases thymopoiesis after androgen withdrawal
Williams, Kirsten M., Lucas, Philip J., Bare, Catherine V., Wang, Jiun, Chu, Yu-Waye, Tayler, Ezekiel, Kapoor, Veena, Gress, Ronald E.
Published in Blood (15.10.2008)
Published in Blood (15.10.2008)
Get full text
Journal Article
Drug interaction potential of trastuzumab emtansine (T-DM1) combined with pertuzumab in patients with HER2-positive metastatic breast cancer
Lu, Dan, Burris, 3rd, Howard A, Wang, Bei, Dees, E Claire, Cortes, Javier, Joshi, Amita, Gupta, Manish, Yi, Joo-Hee, Chu, Yu-Waye, Shih, Ted, Fang, Liang, Girish, Sandhya
Published in Current drug metabolism (01.09.2012)
Published in Current drug metabolism (01.09.2012)
Get more information
Journal Article
Flt3 ligand enhances thymic-dependent and thymic-independent immune reconstitution
Fry, Terry J., Sinha, Manoj, Milliron, Matthew, Chu, Yu-Waye, Kapoor, Veena, Gress, Ronald E., Thomas, Elaine, Mackall, Crystal L.
Published in Blood (01.11.2004)
Published in Blood (01.11.2004)
Get full text
Journal Article
Anti-CD20/CD3 T cell-dependent bispecific antibody for the treatment of B cell malignancies
Sun, Liping L, Ellerman, Diego, Mathieu, Mary, Hristopoulos, Maria, Chen, Xiaocheng, Li, Yijin, Yan, Xiaojie, Clark, Robyn, Reyes, Arthur, Stefanich, Eric, Mai, Elaine, Young, Judy, Johnson, Clarissa, Huseni, Mahrukh, Wang, Xinhua, Chen, Yvonne, Wang, Peiyin, Wang, Hong, Dybdal, Noel, Chu, Yu-Waye, Chiorazzi, Nicholas, Scheer, Justin M, Junttila, Teemu, Totpal, Klara, Dennis, Mark S, Ebens, Allen J
Published in Science translational medicine (13.05.2015)
Published in Science translational medicine (13.05.2015)
Get more information
Journal Article
Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-Hodgkin lymphoma: final results from a phase 2 randomised study (ROMULUS)
Morschhauser, Franck, Flinn, Ian W, Advani, Ranjana, Sehn, Laurie H, Diefenbach, Catherine, Kolibaba, Kathryn, Press, Oliver W, Salles, Gilles, Tilly, Hervé, Chen, Andy I, Assouline, Sarit, Cheson, Bruce D, Dreyling, Martin, Hagenbeek, Anton, Zinzani, Pier Luigi, Jones, Surai, Cheng, Ji, Lu, Dan, Penuel, Elicia, Hirata, Jamie, Wenger, Michael, Chu, Yu-Waye, Sharman, Jeff
Published in The Lancet. Haematology (01.05.2019)
Published in The Lancet. Haematology (01.05.2019)
Get more information
Journal Article
Effects of Trastuzumab Emtansine (T-DM1) on QT Interval and Safety of Pertuzumab Plus T-DM1 in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer
Gupta, Manish, Wang, Bei, Carrothers, Timothy J, LoRusso, Patricia M, Chu, Yu-Waye, Shih, Ted, Loecke, David, Joshi, Amita, Saad, Ola, Yi, Joo-Hee, Girish, Sandhya
Published in Clinical pharmacology in drug development (01.01.2013)
Published in Clinical pharmacology in drug development (01.01.2013)
Get more information
Journal Article
Assessment of Correlation Between Early and Late Efficacy Endpoints to Identify Potential Surrogacy Relationships in Non-Hodgkin Lymphoma: a Literature-Based Meta-analysis of 108 Phase II and Phase III Studies
Zhu, Rui, Lu, Dan, Chu, Yu-Waye, Chai, Akiko, Green, Michelle, Zhang, Nancy, Jin, Jin Yan
Published in The AAPS journal (01.05.2017)
Published in The AAPS journal (01.05.2017)
Get full text
Journal Article
DCDT2980S, an anti-CD22-monomethyl auristatin E antibody-drug conjugate, is a potential treatment for non-Hodgkin lymphoma
Li, Dongwei, Poon, Kirsten Achilles, Yu, Shang-Fan, Dere, Randall, Go, MaryAnn, Lau, Jeffrey, Zheng, Bing, Elkins, Kristi, Danilenko, Dimitry, Kozak, Katherine R, Chan, Pamela, Chuh, Josefa, Shi, Xiaoyan, Nazzal, Denise, Fuh, Franklin, McBride, Jacqueline, Ramakrishnan, Vanitha, de Tute, Ruth, Rawstron, Andy, Jack, Andrew S, Deng, Rong, Chu, Yu-Waye, Dornan, David, Williams, Marna, Ho, William, Ebens, Allen, Prabhu, Saileta, Polson, Andrew G
Published in Molecular cancer therapeutics (01.07.2013)
Published in Molecular cancer therapeutics (01.07.2013)
Get full text
Journal Article